Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Natera, Inc. is a diagnostics company specializing in cell-free DNA technology for non-invasive genetic testing across women’s health, oncology, and organ health. Its core products include prenatal tests, carrier screening, cancer residual disease detection, and transplant rejection monitoring. The company leverages proprietary molecular assays and cloud-based platforms to deliver high-accuracy, scalable solutions globally, serving healthcare providers, laboratories, and patients.
This description was generated via AI from an annual report. Updated about 1 year ago.